Funds › Kahn Brothers Group Inc
Kahn Brothers Group Inc
13F for Q3 2026, filed Nov 16, 2026. 48 positions worth $601.8M.Managers with more than $100 million in US-listed stocks list their holdings each quarter, within 45 days of quarter end. Long positions only: no short sales or cash.
Changes since Q2 2026
3 new, 3 added to, 28 trimmed, 3 exited, 14 unchanged. By estimated dollars.
New positions (3)
Added to (3)
Trimmed (28)
| OGN Organon & Co. | 1.41M | -47.3% | -$17.3M |
| IDT IDT Corporation | 316,325 | -10.0% | -$2.8M |
| GSK GSK plc · ADR | 113,552 | -28.3% | -$2.2M |
| MRK Merck & Company, Inc. | 204,238 | -6.4% | -$2.0M |
| PFE Pfizer, Inc. | 403,301 | -13.1% | -$1.7M |
| SEB Seaboard Corporation | 4,959 | -8.0% | -$1.7M |
| Bayer Ag-Sponsored ADR | 6.42M | -1.5% | -$1.3M |
| BMY Bristol-Myers Squibb Company | 155,297 | -10.8% | -$1.2M |
| GOOG Alphabet Inc. Class C | 118,113 | -2.3% | -$951.7K |
| C Citigroup, Inc. | 829,645 | -0.8% | -$866.5K |
Exited (3)
| Exxon Mobil Corp | 17,655 | Exited | -$2.4M |
| Webster Financial Corp | 4,349 | Exited | -$332.4K |
| ZDGE Zedge, Inc. | 78,126 | Exited | -$242.2K |
The 10 largest of each, by estimated dollars: shares changed times the later report's price. Index tracking, splits and mergers move positions too.
Compare two quarters
Pick any two quarters: what is new, added to, trimmed or exited. Premium plan.
Information, not investment advice. Values are the fund's own figures at quarter end; a report can be up to 45 days old when filed. Disclaimer